Millennium Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-553,684
| Closed | -$9.73M | – | 7808 |
|
|
2021
Q3 | $9.73M | Buy |
553,684
+345,612
| +166% | +$4.04M | 0.01% | 2086 |
|
|
2021
Q2 | $2.02M | Sell |
208,072
-572,686
| -73% | -$5.39M | ﹤0.01% | 3946 |
|
|
2021
Q1 | $8.38M | Sell |
780,758
-90,566
| -10% | -$1.12M | 0.01% | 1982 |
|
|
2020
Q4 | $12.8M | Buy |
871,324
+266,867
| +44% | +$3.85M | 0.01% | 1473 |
|
|
2020
Q3 | $8.59K | Sell |
604,457
-44,396
| -7% | -$443K | 0.01% | 1388 |
|
|
2020
Q2 | $5.25M | Sell |
648,853
-1,094,677
| -63% | -$6.77M | 0.01% | 1724 |
|
|
2020
Q1 | $7.04M | Buy |
+1,743,530
| New | +$6.59M | 0.02% | 1093 |
|
|
2018
Q3 | – | Sell |
-13,704
| Closed | -$82K | – | 4433 |
|
|
2018
Q2 | $82K | Sell |
13,704
-2,822
| -17% | -$18K | ﹤0.01% | 3673 |
|
|
2018
Q1 | $119K | Buy |
16,526
+3,926
| +31% | +$29.8K | ﹤0.01% | 3463 |
|
|
2017
Q4 | $91K | Buy |
12,600
+782
| +7% | +$6.48K | ﹤0.01% | 3672 |
|
|
2017
Q3 | $61K | Buy |
+11,818
| New | +$55.5K | ﹤0.01% | 3394 |
|
|
2017
Q2 | – | Sell |
-10,126
| Closed | -$62K | – | 4021 |
|
|
2017
Q1 | $62K | Sell |
10,126
-4,174
| -29% | -$24.5K | ﹤0.01% | 3368 |
|
|
2016
Q4 | $81K | Sell |
14,300
-2,910
| -17% | -$29K | ﹤0.01% | 3215 |
|
|
2016
Q3 | $254K | Sell |
17,210
-97,286
| -85% | -$1.12M | ﹤0.01% | 2885 |
|
|
2016
Q2 | $1.03M | Sell |
114,496
-139,702
| -55% | -$1.45M | ﹤0.01% | 2151 |
|
|
2016
Q1 | $2.35M | Buy |
254,198
+23,013
| +10% | +$194K | 0.01% | 1688 |
|
|
2015
Q4 | $2.92M | Buy |
231,185
+70,072
| +43% | +$974K | 0.01% | 1695 |
|
|
2015
Q3 | $2.1M | Buy |
161,113
+22,660
| +16% | +$416K | ﹤0.01% | 1868 |
|
|
2015
Q2 | $3.02M | Buy |
+138,453
| New | +$3.16M | 0.01% | 1682 |
|
Other funds holding TRIL
Millennium Management's TRIL Position: Q4 2021 in Review
Millennium Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 553,684 shares — an estimated $9.73M sold.
Millennium Management first reported a position in TRIL in Q2 2015 and held it in 19 quarters. The position peaked at $12.8M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.
- Millennium Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
- Millennium Management sold 553,684 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $9.73M.
- Millennium Management first reported a position in Trillium Therapeutics Inc. in Q2 2015 and held it in 19 quarters.
- Millennium Management's Trillium Therapeutics Inc. position peaked at $12.8M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.
Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.